Brief: Sprint Bioscience Q3 operating result turns to profit of SEK 0.5 mln
Nov 16 (Reuters) - Sprint Bioscience AB SPRINT.ST :
* Q3 revenue 10.8 million Swedish crowns ($1.18 million) versus 4.9 million crowns year ago
* Q3 operating profit 531,000 crowns versus loss 2.6 million crowns year ago
Source text for Eikon: ID:nWkrko4721
Further company coverage: SPRINT.ST
($1 = 9.1772 Swedish crowns)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience And Max IV Receive Funding From Vinnova
Brief: Sprint Bioscience Q2 Loss After Tax SEK 16.2 Million
Brief: Sprint Bioscience Announces Deal With Lilly Tunelab
Brief: Sprint Bioscience Partners With Lilly Tunelab For Drug Development
Brief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln